Similar to the first experiment, MEDI3039 (0.3 mg/kg) treatment induced a modest decrease of Ki67 intensity in tumor samples and increased cleaved caspase-3 (Fig. 4b, c). The gene discussed is CASP3; the disease is neoplasm.